WallStreetZenWallStreetZen

NASDAQ: CHRS
Coherus Biosciences Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Coherus Biosciences earnings were $28.5M for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. The latest CHRS earnings report on Dec 31, 2024 announced Q4 2024 earnings of -$50.7M, up 371.5% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, CHRS reported annual earnings of $28.5M, with -112% growth. The next CHRS earnings date is May 7, 2025.

CHRS past earnings growth

How has CHRS's earnings growth performed historically?

Company
N/A
Industry
11.8%
Market
63.15%
CHRS's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
CHRS's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Market Performance

CHRS earnings history

Current Revenue
$267.0M
Current Earnings
$28.5M
Current Profit Margin
10.7%

CHRS Return on Equity

Current Company
-29.5%
Current Industry
-2%
Current Market
34.1%
CHRS's Return on Equity (-29.5%)... subscribe to Premium to read more.
High Return on Equity Performance

CHRS undefined

Current Company
4.8%
Current Industry
-0.4%
CHRS is generating higher Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when CHRS announces earnings.

CHRS undefined

Current Company
33.62%
Current Industry
5.9%
CHRS has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

CHRS vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
CHRS$62.34M$28.51M-27.98%$0.25
SCPH-$77.43M-$85.15MN/A-$1.91
KRRO-$76.56M-$83.58MN/A-$9.37
ALDX-$53.68M-$55.85MN/A-$0.94
NKTX-$97.35M-$108.79MN/A-$1.60
View Top Biotech Stocks

CHRS earnings dates

Next earnings date
May 7, 2025

Coherus Biosciences Earnings Reports & History FAQ

What were Coherus Biosciences's earnings last quarter?

On CHRS's earnings call on Invalid Date, Coherus Biosciences (NASDAQ: CHRS) reported Q4 2024 earnings per share (EPS) of -$0.44, up 40.54% year over year. Total CHRS earnings for the quarter were -$50.70 million. In the same quarter last year, Coherus Biosciences's earnings per share (EPS) was -$0.74.

If you're new to stock investing, here's how to buy Coherus Biosciences stock.

When does Coherus Biosciences report earnings?

The next CHRS earnings call is Invalid Date. Add CHRS to your watchlist to be reminded of Coherus Biosciences's next earnings date.

What was CHRS's earnings growth in the past year?

As of Coherus Biosciences's earnings date in Invalid Date, Coherus Biosciences's earnings has grown year over year. CHRS earnings in the past year totalled $28.51 million.

Is Coherus Biosciences profitable or losing money?

As of the last Coherus Biosciences earnings report, Coherus Biosciences is currently profitable. Coherus Biosciences's net profit (also called net income) for the twelve months ending Dec 31, 2024 was $28.51 million, a 111.98% decrease year over year.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.